Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...

The US Administration has exempted pharmaceuticals from reciprocal tariffs, highlighting the significance of affordable, life ...

Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel, ...

Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion ...

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...

Food and agriculture remain significantly underfunded compared to other climate tech investments. The World Bank estimates that only 2.5%–4% of global climate ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics ...